Literature DB >> 6399165

Chemical carcinogens without mutagenic activity: peroxisome proliferators as a prototype.

J K Reddy, D G Scarpelli, V Subbarao, N D Lalwani.   

Abstract

Chemical carcinogens can be classified into two categories (i.e. mutagenic and non-mutagenic) on the basis of positive or negative evidence of DNA damage, mutagenicity or chromosomal aberrations in short-term test systems. Evidence indicates that carcinogenic peroxisome proliferators are negative in short-term test systems. This paper outlines approaches which may be useful in identifying a chemical carcinogen without mutagenic activity. It is conceivable that an alteration in DNA, if essential for initiation of neoplasia, may be mediated indirectly by the biological effects of nonmutagenic carcinogens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6399165     DOI: 10.1177/019262338301100209

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes.

Authors:  W E Fahl; N D Lalwani; T Watanabe; S K Goel; J K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

2.  Carcinogenicity studies of some analogs of the carcinogen methapyrilene in F344 rats.

Authors:  W Lijinsky; R M Kovatch
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 3.  An overview of peroxisome proliferator-induced hepatocarcinogenesis.

Authors:  M S Rao; J K Reddy
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 4.  Measurement of ploidy and cell proliferation in the rodent liver.

Authors:  J A Styles
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

5.  Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.

Authors:  M S Rao; R S Dwivedi; V Subbarao; J K Reddy
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

6.  Overview of the marmoset as a model in nonclinical development of pharmaceutical products.

Authors:  Antonia Orsi; Daryl Rees; Isabella Andreini; Silvana Venturella; Serena Cinelli; Germano Oberto
Journal:  Regul Toxicol Pharmacol       Date:  2010-12-13       Impact factor: 3.271

7.  Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.

Authors:  J K Reddy; M K Reddy; M I Usman; N D Lalwani; M S Rao
Journal:  Environ Health Perspect       Date:  1986-03       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.